Physician profile
Charley Gates
NPI 1013119528
$5,976.81
in general payments reported to CMS, 2019-2025
12 companies · $78.98 in 2025
The $78.98 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,334 · 2020: $2,159 · 2021: $165 · 2022: $116 · 2023: $79.90 · 2024: $43.30 · 2025: $78.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $202.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,651.95 | 2019-2021 | |
| Stryker Corporation | $1,638.82 | 2019-2025 | Augment Injectable |
| Conformis, INC. | $1,454.79 | 2019-2021 | |
| Mid-Atlantic Surgical Systems, LLC | $613.80 | 2019 | |
| Depuy Synthes Sales INC. | $299.91 | 2019-2022 | |
| Medical Device Business Services, INC. | $78.77 | 2019 | |
| Exactech, INC. | $73.66 | 2020 | |
| Innovation Technologies INC | $61.28 | 2023 | Irrisept |
| Bioventus LLC | $32.13 | 2024 | Durolane |
| Heraeus Medical, LLC. | $26.69 | 2022-2024 | |
| Baxter Healthcare | $26.39 | 2025 | Floseal |
| Pacira Pharmaceuticals Incorporated | $18.62 | 2023 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charley Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.